AlphaFold predicted structure
BLNK · Q8WV28

Mean pLDDT
63.7/ 100
Low
456 residues
Confidence breakdown
- Very high(≥ 90)22%
- Confident(70–90)9%
- Low(50–70)35%
- Very low(< 50)33%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
B cell linker
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
COVID-19 research
BIALLELIC, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalisolated agammaglobulinemia
autosomal agammaglobulinemia
agammaglobulinemia
alcohol drinking
neuroendocrine neoplasm
Abnormality of the gastrointestinal tract
substance abuse
attention deficit-hyperactivity disorder
aging
hereditary disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
B-cell linker protein
Functions as a central linker protein, downstream of the B-cell receptor (BCR), bridging the SYK kinase to a multitude of signaling pathways and regulating biological outcomes of B-cell function and development. Plays a role in the activation of ERK/EPHB2, MAP kinase p38 and JNK. Modulates AP1 activation. Important for the activation of NF-kappa-B and NFAT. Plays an important role in BCR-mediated PLCG1 and PLCG2 activation and Ca(2+) mobilization and is required for trafficking of the BCR to late endosomes. However, does not seem to be required for pre-BCR-mediated activation of MAP kinase and phosphatidyl-inositol 3 (PI3) kinase signaling. May be required for the RAC1-JNK pathway. Plays a critical role in orchestrating the pro-B cell to pre-B cell transition. May play an important role in BCR-induced B-cell apoptosis
BLNK · Q8WV28

Mean pLDDT
63.7/ 100
Low
456 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0